Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group.
作者信息
Gøtzsche P
出版信息
BMJ. 1993 Sep 11;307(6905):682-3. doi: 10.1136/bmj.307.6905.682-b.
Abstract
摘要
相似文献
1
Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group.
BMJ. 1993 Sep 11;307(6905):682-3. doi: 10.1136/bmj.307.6905.682-b.
2
[Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
Ugeskr Laeger. 1993 Jan 11;155(2):104-7.
3
Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.
BMJ. 1992 Jan 4;304(6818):13-7. doi: 10.1136/bmj.304.6818.13.
4
FDA Committee recommends clearance for HIVID combination therapy.
AIDS Patient Care STDS. 1996 Jun;10(3):186.
5
A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.
N Engl J Med. 1992 Feb 13;326(7):437-43. doi: 10.1056/NEJM199202133260703.
6
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Lancet. 1999 Jun 12;353(9169):2014-25.
7
Effectiveness of zidovudine in treatment of advanced HIV infection.
JAMA. 1994 Apr 13;271(14):1121-2.
8
Zidovudine: clinical experience in symptomatic HIV disease.
AIDS Clin Rev. 1989:221-42.
9
A new HIV/AIDS drug.
J Ark Med Soc. 1996 Jan;92(8):407.
10
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
J Infect Dis. 1999 Sep;180(3):659-65. doi: 10.1086/314948.
引用本文的文献
1
Zidovudine dosage.
BMJ. 1993 Nov 27;307(6916):1423. doi: 10.1136/bmj.307.6916.1423-b.
2
Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.
Clin Pharmacokinet. 1995 Jul;29(1):46-65. doi: 10.2165/00003088-199529010-00006.
本文引用的文献
1
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
N Engl J Med. 1990 Oct 11;323(15):1009-14. doi: 10.1056/NEJM199010113231501.
2
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
N Engl J Med. 1990 Apr 5;322(14):941-9. doi: 10.1056/NEJM199004053221401.
Zotero 插件